Skip to content
Disclosery

Legal Advantage Investments, Inc.: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Legal Advantage Investments, Inc. on GSK, newest first. How the timeline and the estimate are built.

Legal Advantage Investments, Inc. held 6,150 GSK shares at 2026-09-30 per its 13F-HR filed 2026-10-13.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 6,150 shares
    Change vs previous 13F 0 shares

    0.06% of the 13F portfolio, value $296,246.

    13F-HR 0001172661-26-004504 filed by Legal Advantage Investments, Inc.
    Accepted , ingested

  2. period ended2026-06-30
    13F 6,150 shares
    Change vs previous 13F 0 shares

    0.11% of the 13F portfolio, value $322,383.

    13F-HR 0001172661-26-002624 filed by Legal Advantage Investments, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 6,150 shares
    Change vs previous 13F 0 shares

    0.18% of the 13F portfolio, value $339,418.

    13F-HR 0001172661-26-001509 filed by Legal Advantage Investments, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 6,150 shares
    Change vs previous 13F 0 shares

    0.14% of the 13F portfolio, value $301,596.

    13F-HR 0001172661-26-000183 filed by Legal Advantage Investments, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 6,150 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $265,434.

    13F-HR 0001172661-25-004327 filed by Legal Advantage Investments, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).